Strategic Innovations
Yongbao Wang, PhD, Director
National Jewish Health Advanced Diagnostic Laboratories provides customized assay development to support clinical trials projects. Our team of scientists is dedicated to specialized assay development and automation of processes. We specialize in molecular identification built for CAP/CLIA laboratory use.
Strategic Innovations Projects
Since 2019, we have developed and improved specialized test panels including:
Rapid Pathogen ID (RPID) for screening donor tissue for pathogen contamination
COVID 19 Variant testing panel
The most comprehensive Alpha-1 Antitrypsin Genotype panel, assessing 23 SNPs.
TB screening for minimally processed bone tissue
510k instrument validation for a global diagnostic manufacturer
We have also worked to migrate existing panels to automated processes, including the CH50 and AH50 hemolytic assay.
Reach out to us if you are interested in custom assay design or development for your projects.
Yongbao Wang, PhD